OFIX - Orthofix gets FDA clearance and CE Mark for its limb preservation solution
2025-03-19 10:13:02 ET
More on Orthofix Medical Inc.
- Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript
- Orthofix Medical Inc. 2024 Q4 - Results - Earnings Call Presentation
- Orthofix Medical Inc. GAAP EPS of -$0.75 misses by $0.52, revenue of $215.7M beats by $2.98M
- Seeking Alpha’s Quant Rating on Orthofix Medical Inc.
- Historical earnings data for Orthofix Medical Inc.